EKF Diagnostics (LON:EKF) Posts Earnings Results

EKF Diagnostics (LON:EKF) issued its quarterly earnings results on Tuesday. The company reported GBX 0.47 earnings per share for the quarter, Digital Look Earnings reports. EKF Diagnostics had a net margin of 12.19% and a return on equity of 8.50%.

EKF Diagnostics Stock Performance

Shares of EKF stock opened at GBX 23.42 on Tuesday. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.77 and a current ratio of 4.62. The firm has a market cap of £101.15 million, a price-to-earnings ratio of 17.35 and a beta of 0.53. EKF Diagnostics has a 52 week low of GBX 19 and a 52 week high of GBX 32. The firm’s 50-day simple moving average is GBX 25.75 and its two-hundred day simple moving average is GBX 26.44.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

? Point-of-Care analysers in the key areas of Hematology and Diabetes

? Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.